drugset / Trial / NCT01562834
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to assess the effect of somatropin (Norditropin®) replacement therapy on the left ventricular mass of adult patients with a growth hormone deficiency.
Timeline
- Start
- 1998-10-21
- Primary completion
- 2002-12-01
- Completion
- 2002-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.5 iu | Subcutaneous |
Indications
No indication recorded.